Pegylated Somatotropin (PEG-GH) from Japan
Pegylated Somatotropin (PEG-GH) is human somatotropin conjugated with polyethylene glycol (PEG) to extend its half-life and reduce injection frequency. This structural modification creates a derivative of somatotropin used primarily for its hormonal effect in growth hormone therapy. The PEGylation does not alter the core hormonal function, making it classifiable under somatotropin derivatives.
Duty Rate — Japan → Canada
0%
Import Tips
• Document the PEGylation process and the product's hormonal activity to demonstrate it is a somatotropin derivative
• Provide the CAS number and structural information to the CBSA for accurate classification
• Verify if the product requires regulatory approval from Health Canada before importation